...
首页> 外文期刊>Asian Pacific Journal of Cancer Prevention >Prognostic Evaluation of Categorical Platelet-based Indices Using Clustering Methods Based on the Monte Carlo Comparison for Hepatocellular Carcinoma
【24h】

Prognostic Evaluation of Categorical Platelet-based Indices Using Clustering Methods Based on the Monte Carlo Comparison for Hepatocellular Carcinoma

机译:基于Monte Carlo对肝细胞癌的蒙特卡罗比较的聚类方法预后评估基于分类的血小板索引

获取原文
           

摘要

Objectives: To evaluate the performance of clustering methods used in the prognostic assessment of categorical clinical data for hepatocellular carcinoma (HCC) patients in China, and establish a predictable prognostic nomogram for clinical decisions. Materials and Methods: A total of 332 newly diagnosed HCC patients treated with hepatic resection during 2006-2009 were enrolled. Patients were regularly followed up at outpatient clinics. Clustering methods including the Average linkage, k-modes, fuzzy k-modes, PAM, CLARA, protocluster, and ROCK were compared by Monte Carlo simulation, and the optimal method was applied to investigate the clustering pattern of the indices including platelet count, platelet/lymphocyte ratio (PLR) and serum aspartate aminotransferase activity/platelet count ratio index (APRI). Then the clustering variable, age group, tumor size, number of tumor and vascular invasion were studied in a multivariable Cox regression model. A prognostic nomogram was constructed for clinical decisions. Results: The ROCK was best in both the overlapping and non-overlapping cases performed to assess the prognostic value of platelet-based indices. Patients with categorical platelet-based indices significantly split across two clusters, and those with high values, had a high risk of HCC recurrence (hazard ratio [HR] 1.42, 95% CI 1.09-1.86; p0.01). Tumor size, number of tumor and blood vessel invasion were also associated with high risk of HCC recurrence (all p 0.01). The nomogram well predicted HCC patient survival at 3 and 5 years. Conclusions: A cluster of platelet-based indices combined with other clinical covariates could be used for prognosis evaluation in HCC.
机译:目的:评价中国肝细胞癌(HCC)患者的分类临床数据的预后评估中使用的聚类方法的性能,并建立可预测的临床决策预后探测图。材料和方法:在2006 - 2009年期间共有332例新诊断的HCC患者治疗肝切除术治疗。患者经常随访门诊诊所。通过Monte Carlo模拟比较包括平均联系,K-MOD,模糊k模式,PAM,Clara,Protocluster和Rock的聚类方法,并应用了最佳方法来调查包括血小板计数,血小板的指数的聚类模式/淋巴细胞比(PLR)和血清天冬氨酸氨基转移酶活性/血小板计数比指数(APRI)。然后在多变量的Cox回归模型中研究了聚类变量,年龄组,肿瘤大小,肿瘤和血管侵袭的数量。为临床决策构建了预后的NOM图。结果:岩石在重叠和非重叠案件中最好进行,以评估基于血小板的索引的预后价值。基于分类的基于血小板的诊断患者显着分裂在两个簇中,并且具有高值的人具有高风险的HCC复发风险(危险比[HR] 1.42,95%CI 1.09-1.86; P <0.01)。肿瘤大小,肿瘤和血管侵袭的数量也与HCC复发的高风险有关(所有P <0.01)。 NOMAROM良好预测HCC患者生存在3和5年。结论:与其他临床协变量相结合的基于血小板的索引可用于HCC的预后评估。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号